Evidence map›Paper›PMID 30405884›Full record

ArticleOncotarget2018

Exosomal survivin facilitates vesicle internalization.

Amber Gonda, Janviere Kabagwira, Girish N Senthil, Heather R Ferguson Bennit, Jonathan W Neidigh, Salma Khan, Nathan R Wall

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Extracellular vesicles in bone aging: therapeutic strategies and applications.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Exosomal RNAs in diagnosis and therapies.Non-coding RNA research · 2022
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amber GondaCenter for Health Disparities Research and Molecular Medicine, Loma Linda University, Loma Linda, California, 92350, USA.
Janviere KabagwiraCenter for Health Disparities Research and Molecular Medicine, Loma Linda University, Loma Linda, California, 92350, USA.
Girish N SenthilCenter for Health Disparities Research and Molecular Medicine, Loma Linda University, Loma Linda, California, 92350, USA.
Heather R Ferguson BennitCenter for Health Disparities Research and Molecular Medicine, Loma Linda University, Loma Linda, California, 92350, USA.
Jonathan W NeidighDepartment of Basic Sciences, Division of Biochemistry, Loma Linda University, Loma Linda, California, 92350, USA.
Salma KhanCenter for Health Disparities Research and Molecular Medicine, Loma Linda University, Loma Linda, California, 92350, USA.
Nathan R WallCenter for Health Disparities Research and Molecular Medicine, Loma Linda University, Loma Linda, California, 92350, USA.
Loma Linda University · US

Funding

Research Training/Education CoreP20MD006988 · NIMHD · LOMA LINDA UNIVERSITY · PI DE LEON, MARINO · 2012 to 2016
$6.2M
NIMHD NIH HHS P20 MD006988
6 · The paper itself

Abstract

Survivin, a member of the inhibitor of apoptosis (IAP) protein family plays a significant role in cell fate and function. It is significantly overexpressed in tumor cells and has been identified in most cancer cell types. A novel extracellular population has recently been identified and its function is still unknown. Emerging evidence continues to shed light on the important role the tumor microenvironment (TME) has on tumor survival and progression. This new population of survivin has been seen to enhance the tumor phenotype when internalized by recipient cells. In this paper, we sought to better understand the mechanism by which survivin is taken up by cancer cells and the possible role it plays in this phenomenon. We isolated the exosomal carriers of extracellular survivin and using a lipophilic stain, PKH67, we tracked their uptake with immunofluorescence and flow cytometry. We found that by blocking exosomal survivin, exosome internalization is reduced, signifying a novel function for this protein. We also discovered that the common membrane receptors, transferrin receptor, endothelin B receptor, insulin receptor alpha, and membrane glucocorticoid receptor all facilitate exosomal internalization. This understanding further clarifies the protein-protein interactions in the TME that may influence tumor progression and identifies additional potential chemotherapeutic targets.

Indexed as

cancer targetsexosomemembrane receptorssurvivintransferrin

Identifiers

PMID30405884
PMCPMC6201849
OpenAlexW2896765746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.